The Foundation of the Spanish Society of Endocrinology and Nutrition grants a research project on vascular risk factors of IRBLleida
The Basic and Clinical Group of Immunology and Endocrinology carries out the project 'Advanced glycation end products and atheromatous charge: role of fluorescence in plaque formation'
The Spanish Society of Endocrinology and Nutrition Foundation (FSEEN) has awarded the research project 'Advanced glycation end products and atheromatous load: role of fluorescence in plaque formation' of the Basic and Clinical Group of Immunology and Endocrinology of IRBLleida, a group Consolidated of the University of Lleida, of the Endocrinology and Nutrition Service of the Arnau de Vilanova University Hospital (HUAV).
The study has been awarded € 4,500 in the framework of aid for research into vascular risk factors. This economic endowment will allow to continue with the study of the direct relationship between the proteins called advanced glycation end products, Advanced Glycation End Products (AGE), in the process of atherosclerotic plaque (fat) formation in the arteries.
